USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

Aug 2022| MKB904AS| TBRC (Publisher)

Report Highlights

The USA lateral flow immunoassay (LFIA) based rapid test market grew from $1,793.2 million in 2016 to $3,714.8 million in 2021 at a compound annual growth rate (CAGR) of 15.7%. The USA lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $3,714.8 million in 2021 to $2,346 million in 2026 at a compound annual growth rate (CAGR) of -8.8%.

USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022 provides strategists, marketers and senior management with the critical information they need to assess the USA Lateral Flow Immunoassay (LFIA) Based Rapid Test market.

Reasons to Purchase

  • Fully updated for 2022.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.

Description

USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022 from the Business Research Company covers market characteristics, size and growth, trends and strategies for this market.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the Lateral Flow Immunoassay (LFIA) Based Rapid Test market revenues, covering both the historic growth of the market and forecasting the future.
  • The trends and strategies section highlights the likely future developments in the Lateral Flow Immunoassay (LFIA) Based Rapid Test market and suggests approaches.

 

 

Frequently Asked Questions (FAQs)

1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904A

2. Asia Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AA

3. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AB

Scope

Markets Covered: Lateral Flow Immunoassay (LFIA) Based Rapid Test

Geographic scope: USA

Time series: Five years historic and forecast

Data: Market value in $ billions.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : USA GDP Per Capita, 2015-2020, $
  • Table 2 : USA, Population By Age Group, 2015-2025, Thousands
  • Table 3 : USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 4 : USA Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 5 : USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
  • Table 6 : USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 7 : USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 8 : USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 9 : Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Data Sources
  • Figure 1 : USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
  • Figure 2 : USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 3 : USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Asia Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AA

The Asia Pacific lateral flow immunoassay (LFIA) based rapid test market grew from $1547.8 million in 2016 to $2,924.5 million in 2021 at a compound annual growth rate (CAGR) of 13.6%. The Asia Pacific lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $2924.5 million in 2021 to $1666.6 million in 2026 at a compound annual ...

North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AB

The North America lateral flow immunoassay (LFIA) based rapid test market grew from $1,988.5 million in 2016 to $4,145.4 million in 2021 at a compound annual growth rate (CAGR) of 15.8%. The North America lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $4,145.4 million in 2021 to $2,656.3 million in 2026 at a compound annual ...

Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AD

The Eastern Europe lateral flow immunoassay (LFIA) based rapid test market grew from $248.1 million in 2016 to $492.3 million in 2021 at a compound annual growth rate (CAGR) of 14.7%. The Eastern Europe lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $492.3 million in 2021 to $301.9 million in 2026 at a compound annual ...

Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AC

The Western Europe lateral flow immunoassay (LFIA) based rapid test market grew from $1,240.4 million in 2016 to $2,500.6 million in 2021 at a compound annual growth rate (CAGR) of 15.1%. The Western Europe lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $2,500.6 million in 2021 to $1,592.7 million in 2026 at a compound annual ...

South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AE

The South America lateral flow immunoassay (LFIA) based rapid test market grew from $222.7 million in 2016 to $397 million in 2021 at a compound annual growth rate (CAGR) of 12.3%. The South America lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $397.0 million in 2021 to $222.9 million in 2026 at a compound annual ...

Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AF

The Africa lateral flow immunoassay (LFIA) based rapid test market grew from $145.0 million in 2016 to $229.3 million in 2021 at a compound annual growth rate (CAGR) of 9.6%. The Africa lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $229.3 million in 2021 to $158.9 million in 2026 at a compound annual growth rate ...

Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AG

The Middle East lateral flow immunoassay (LFIA) based rapid test market grew from $213.5 million in 2016 to $361.7 million in 2021 at a compound annual growth rate (CAGR) of 11.1%. The Middle East lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $361.7 million in 2021 to $237.3 million in 2026 at a compound annual ...

China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AH

The China lateral flow immunoassay (LFIA) based rapid test market grew from $672.6 million in 2016 to $1,259.8 million in 2021 at a compound annual growth rate (CAGR) of 13.4%. The China lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $1,259.8 million in 2021 to $707.6 million in 2026 at a compound annual growth rate ...

India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AI

The India lateral flow immunoassay (LFIA) based rapid test market grew from $139 million in 2016 to $261.9 million in 2021 at a compound annual growth rate (CAGR) of 13.5%. The India lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $261.9 million in 2021 to $138.7 million in 2026 at a compound annual growth rate ...

Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AJ

The Japan lateral flow immunoassay (LFIA) based rapid test market grew from $300.8 million in 2016 to $580 million in 2021 at a compound annual growth rate (CAGR) of 14.0%. The Japan lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $580 million in 2021 to $335.3 million in 2026 at a compound annual growth rate ...

Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AK

The Australia lateral flow immunoassay (LFIA) based rapid test market grew from $84.7 million in 2016 to $163.1 million in 2021 at a compound annual growth rate (CAGR) of 14.0%. The Australia lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $163.1 million in 2021 to $96.4 million in 2026 at a compound annual growth rate ...

Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AL

The Indonesia lateral flow immunoassay (LFIA) based rapid test market grew from $53.5 million in 2016 to $96 million in 2021 at a compound annual growth rate (CAGR) of 12.4%. The Indonesia lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $96 million in 2021 to $54.1 million in 2026 at a compound annual growth rate ...

South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AM

The South Korea lateral flow immunoassay (LFIA) based rapid test market grew from $80.2 million in 2016 to $155.9 million in 2021 at a compound annual growth rate (CAGR) of 14.2%. The South Korea lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $155.9 million in 2021 to $93.3 million in 2026 at a compound annual ...

UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AN

The UK lateral flow immunoassay (LFIA) based rapid test market grew from $140.4 million in 2016 to $289.1 million in 2021 at a compound annual growth rate (CAGR) of 15.5%. The UK lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $289.1 million in 2021 to $180 million in 2026 at a compound annual growth rate ...

Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AO

The Germany lateral flow immunoassay (LFIA) based rapid test market grew from $280.4 million in 2016 to $569.4 million in 2021 at a compound annual growth rate (CAGR) of 15.2%. The Germany lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $569.4 million in 2021 to $358.2 million in 2026 at a compound annual growth rate ...

France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AP

The France lateral flow immunoassay (LFIA) based rapid test market grew from $179.4 million in 2016 to $340.6 million in 2021 at a compound annual growth rate (CAGR) of 13.7%. The France lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $340.6 million in 2021 to $210.5 million in 2026 at a compound annual growth rate ...

Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AQ

The Russia lateral flow immunoassay (LFIA) based rapid test market grew from $93.2 million in 2016 to $181.9 million in 2021 at a compound annual growth rate (CAGR) of 14.3%. The Russia lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $181.9 million in 2021 to $106.3 million in 2026 at a compound annual growth rate ...

Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022

  • Date - Aug 2022
  • Code - MKB904AR

The Brazil lateral flow immunoassay (LFIA) based rapid test market grew from $102.9 million in 2016 to $182.0 million in 2021 at a compound annual growth rate (CAGR) of 12.1%. The Brazil lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $182.0 million in 2021 to $105.6 million in 2026 at a compound annual growth rate ...

The Business Research Company
Price: $2500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS